Prognostic implications of expression of the cell cycle inhibitor protein p27Kip1 Sandrine CariouCharles CatzavelosJoyce M. Slingerland OriginalPaper Pages: 29 - 41
The type 1 growth factor receptor family: new ligands and receptors and their role in breast cancer William John GullickRadhika Srinivasan OriginalPaper Pages: 43 - 53
c-erbB2 expression predicts tamoxifen efficacy in breast cancer patients Sabino De PlacidoChiara CarlomagnoAngelo Raffaele Bianco OriginalPaper Pages: 55 - 64
Her-2/neu as a Predictive Marker of Response to Breast Cancer Therapy Mark D. PegramGiovanni PaulettiDennis J. Slamon OriginalPaper Pages: 65 - 77
Prognostic and predictive value of p53 and p21 in breast cancer Richard M. ElledgeD. Craig Allred OriginalPaper Pages: 79 - 98
The urokinase plasminogen activator system as a target for prognostic studies in breast cancer Ross W. StephensNils BrünnerManfred Schmitt OriginalPaper Pages: 99 - 111
Metalloproteinases and tissue inhibitors of metalloproteinases Masakazu ToiShinsuke IshigakiTakeshi Tominaga OriginalPaper Pages: 113 - 124
The 67 kDa laminin receptor as a prognostic factor in human cancer Sylvie MénardElda TagliabueMaria Ines Colnaghi OriginalPaper Pages: 137 - 145
Assessment of intratumoral vascularization (angiogenesis) in breast cancer prognosis Ruth HeimannDonald FergusonSamuel Hellman OriginalPaper Pages: 147 - 158
Clinical significance of angiogenic factors in breast cancer Nathalia LocopoMassimo FanelliGiampietro Gasparini OriginalPaper Pages: 159 - 173
Insulin-like growth factors in human breast cancer Matthew J. EllisSara JenkinsAdrian Harris OriginalPaper Pages: 175 - 184
Molecular prognostic markers in breast cancer Rajvir DahiyaGuoren Deng OriginalPaper Pages: 185 - 200
Prognostic significance of micrometastatic bone marrow involvement Stephan BraunKlaus Pantel OriginalPaper Pages: 201 - 216
Timing of surgery for primary breast cancer with regard to the menstrual phase and prognosis Ismail Jatoi OriginalPaper Pages: 217 - 225
Time-dependence of hazard ratios for prognostic factors in primary breast cancer Susan G. HilsenbeckPeter M. RavdinGary M. Clark OriginalPaper Pages: 227 - 237
Circulating tumor markers in breast cancer: Accepted utilities and novel prospects Vered StearnsHideko YamauchiDaniel F. Hayes OriginalPaper Pages: 239 - 259
The relationship between prognostic and predictive factors in the management of breast cancer I. Craig HendersonAnthony J. Patek OriginalPaper Pages: 261 - 288
Methodological challenges in the evaluation of prognostic factors in breast cancer Douglas G. AltmanGary H. Lyman OriginalPaper Pages: 289 - 303
Assessing the clinical impact of prognostic factors: When is "statistically significant" clinically useful? Daniel F. HayesBruce TrockAdrian L. Harris OriginalPaper Pages: 305 - 319
Prognostic variables in node-negative and node-positive breast cancer - editorial Giampietro Gasparini OriginalPaper Pages: 321 - 331